Brainstorm Cell Therapeutics Inc. Stock Forecast
Green day on Friday for Brainstorm Cell Therapeutics Inc. stock after gaining 0.470%
(Updated on Apr 26, 2024)
The Brainstorm Cell Therapeutics Inc. stock price gained 0.470% on the last trading day (Friday, 26th Apr 2024), rising from $0.532 to $0.535. During the last trading day the stock fluctuated 6.75% from a day low at $0.520 to a day high of $0.555. The price has been going up and down for this period, and there has been a -8.48% loss for the last 2 weeks. Volume fell on the last day by -3 thousand shares and in total, 264 thousand shares were bought and sold for approximately $141.36 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.467 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 58.27% during the next 3 months and, with a 90% probability hold a price between $0.738 and $1.32 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
BCLI Signals & Forecast
There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -27.76%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. The Brainstorm Cell Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.532 and $0.531. A breakdown below any of these levels will issue sell signals.
Support, Risk & Stop-loss for Brainstorm Cell Therapeutics Inc. stock
Brainstorm Cell Therapeutics Inc. finds support from accumulated volume at $0.532 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0351 between high and low, or 6.75%. For the last week the stock has had daily average volatility of 8.45%.
Brainstorm Cell Therapeutics Inc. is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: $0.510 (-4.58%) (This stock has very high daily movements and this gives very high risk. Low RSI14 is 24 which reduces the risk some. There is a sell signal from a pivot top found 19 days ago.)
Trading Expectations (BCLI) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect Brainstorm Cell Therapeutics Inc. to open at $0.537, and during the day (based on 14 day Average True Range), to move between $0.455 and $0.614, which gives a possible trading interval of +/-$0.0791 (+/-14.79%) up or down from last closing price. If Brainstorm Cell Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 29.59% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.532 (0.47%) than the resistance at $0.570 (6.64%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Brainstorm Cell Therapeutics Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Brainstorm Cell Therapeutics Inc. stock to perform well in the short-term.
Current score: 3.513 Buy Candidate Unchanged
Predicted Opening Price for Brainstorm Cell Therapeutics Inc. of Monday, April 29, 2024
| Fair opening price April 29, 2024 | Current price |
|---|---|
| $0.537 ( 0.380%) | $0.535 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for BCLI
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.572 | 6.95 % | |
| R2 | 0.558 | 4.44 % | ||
| R1 | 0.550 | 2.89 % | ||
| Current price: | 0.535 | |||
| Support | S1 | 0.523 | -2.13 % | |
| S2 | 0.515 | -3.68 % | ||
| S3 | 0.501 | -6.19 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.655 | 22.54 % | |
| R2 | 0.583 | 8.98 % | ||
| R1 | 0.570 | 6.64 % | ||
| Current price | 0.535 | |||
| Support | S1 | 0.532 | -0.468% | |
| S2 | 0.507 | -5.14% | ||
| S3 | 0.480 | -10.20% |
FAQ
Click here for our free guide on how to buy Brainstorm Cell Therapeutics Inc. Stock.
